Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping birds are enveloping the comfy
The development agreement will see Fresenius Kabi’s cell therapy processing technologies integrated into Cellular Origins’ robotic platform. Credit: Kotin/Shutterstock. Fresenius Kabi and Cellular Origins have
What You Should Know: – OPTAC-X, a leader in telehealth solutions, and Mayo Clinic have achieved a milestone in emergency medicine by utilizing satellite-enabled telehealth
Epioxa was developed to be used during the corneal cross-linking procedure to treat keratoconus. Credit: MacroEcon/Shutterstock. Glaukos plans to file for US approval of its
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. I had the
What You Should Know: – A new survey from PwC highlights significant disparities in how consumers experience the U.S. healthcare system with 65% of consumers
University of Florida Health scientists exploring how combinations of antibiotics can fight resistant bacteria have been awarded an $11.8 million grant for work that could
A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or
Cognitive behavioral therapy for insomnia (CBTI) delivered during pregnancy significantly reduces postpartum depressive symptoms in mothers, new research from UBC shows.
Although there has been a slight downward trend in the prescription of benzodiazepines (depressants that relieve anxiety, muscle spasms, produce sedation and reduce seizures) among